4//SEC Filing
YOUNG KEVIN 4
Accession 0001127602-17-025602
CIK 0000882095other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:57 PM ET
Size
8.0 KB
Accession
0001127602-17-025602
Insider Transaction Report
Form 4
YOUNG KEVIN
EVP, Commercial Operations
Transactions
- Exercise/Conversion
Restricted Stock Unit
2017-08-10−910→ 4,712 total→ Common Stock (910 underlying) - Tax Payment
Common Stock
2017-08-10$72.70/sh−453$32,933→ 6,688 total - Exercise/Conversion
Common Stock
2017-08-10+910→ 7,141 total
Footnotes (2)
- [F1]The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
- [F2]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Documents
Issuer
GILEAD SCIENCES INC
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001303643
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:57 PM ET
- Size
- 8.0 KB